Is Informa Stock a Good Investment in 2026? INF Fundamentals Explained

Informa has agreed to acquire Clarion Events from Blackstone at an enterprise value of £2.24bn, and is paying for a large slice of it by issuing new equity: roughly £940m of gross proceeds from 109,302,326 new shares placed at 860p, about 8.7% of the existing share capital. The announcement on 6 October 2026 came alongside a second, arguably larger decision — a formal process to separate Taylor & Francis, the academic publishing division that produced £670.8m of revenue in 2025 at an adjusted operating margin of 36.6%. The shares rose about 3%, closing at 887p.

So anyone asking whether Informa stock is a good investment is now asking a different question than they were a week ago. The company that existed on 5 October was a hybrid: a fast-growing B2B exhibitions business bolted to a high-margin, slow-growing academic publisher whose subscription revenues smoothed the cyclicality of the events cycle. The company being proposed is a near pure-play B2B live events group, larger, more exposed to the trade-show cycle, and carrying more debt. What the numbers support is that the events business is genuinely compounding — 8% underlying revenue growth in the first half of 2026, with group guidance reaffirmed at 6% underlying and 7%-plus for B2B Live Events. What has to go right is the funding structure and the timing: the £2.24bn is spent at completion in the fourth quarter of 2026, the £75m of annual benefits management has identified does not arrive in full until 2029, and the proceeds from Taylor & Francis — the obvious offset — are not priced, not committed, and not expected to be resolved until the full-year results in March 2027.

What Informa actually announced

Two things, deliberately on the same day. The first is the Clarion acquisition. Clarion is a UK-based owner of more than 100 B2B live event brands spanning defence and security, technology, gaming, energy and travel — the DSEI defence exhibition and the ICE gaming show are among its assets. Informa is paying £2.24bn of enterprise value, quoted elsewhere as roughly $2.96bn. Management has guided that Clarion should generate revenues above $760m (c.£575m) in calendar 2027, at an adjusted operating profit margin above 30%.

On the company's own framing, £2.24bn represents 11.1 times expected 2027 EBITDA. Including the £50m of annual operating synergies Informa has identified — from operating model efficiencies and the removal of duplicated corporate costs — that multiple falls to roughly 9 times. Including a further £25m of operating profit management expects to generate from incremental revenue by 2029, it falls to roughly 8 times. It is worth being precise about that split, because the headline £75m is not one number: £50m is cost takeout, which companies generally deliver, and £25m is revenue synergy, which is a forecast about customer behaviour. One-off costs to deliver the synergies are expected to be around £50m. Completion is guided for the fourth quarter of 2026, subject to regulatory clearances.

The second announcement is the separation of Taylor & Francis. Informa has launched a formal process to review all options — which is not the same as committing to a sale or a demerger — for a division whose annual revenue is approaching $1bn and growing at around 4% a year. In 2025 Taylor & Francis reported revenue of £670.8m, down 3.9% on a reported basis but up 3.6% underlying once non-recurring data access contracts are excluded, with adjusted operating profit of £245.7m. The outcome will be reported alongside the full-year results in March 2027.

Put the two together and the destination is explicit. After Clarion completes, Informa's B2B Live Events division would make sales of more than £4.2bn across around 1,000 specialist brands, in more than 40 market categories and over 30 countries. Chief executive Stephen A. Carter's own wording tied the moves together: the separation of Taylor & Francis coincides with "further expansion in B2B through the acquisition of Clarion".

Why the market reacted the way it did

A 3% rise on the day a company announces a £2.24bn acquisition and a near-9% share issue is not a trivial reaction. Equity raises of that size are usually met with a fall, because existing holders are diluted and the placing is struck at a discount to the prevailing price. Informa's was placed at 860p, essentially at the previous close rather than at the level the shares traded up to during the session.

Three things appear to explain the reception. First, the strategic logic is simple and investors had been primed for it: Informa has spent several years telling the market that B2B live events is the growth engine, and Blackstone's intention to exit Clarion had been public for some time. Second, the funding is more conservative than it might have been. By taking £940m in equity rather than putting the whole £2.24bn on the balance sheet, Informa has kept its leverage within the range it has guided to — pro-forma net debt to EBITDA is expected to stay below 3 times at the end of 2026 and fall to under 2.5 times by the end of 2027, against adjusted leverage of 2.4 times and net debt of £3,027.5m at 30 June 2026. Third, the market is treating Taylor & Francis as a source of value that is about to be crystallised rather than a division being abandoned.

The reaction is best read as approval of the direction, not a verdict on the price. The 11.1 times multiple is paid today; the 9 times and 8 times versions of it depend on execution that runs to 2029.

The Openbook read

Momentum. The underlying trading momentum is real and predates this deal: 8% underlying revenue growth in B2B Live Events in the first half of 2026, with Informa Markets at 10.4%, achieved despite the rescheduling of more than 15 major brands in India, the Middle East and Africa from the first half into the second. Around 80% of 2026 targeted revenues were already committed or visible through subscriptions, forward bookings and contracts. Momentum is the least contested of the five factors here.

Growth. Clarion adds scale rather than a new growth rate. A business guided to above $760m of 2027 revenue at a 30%-plus adjusted operating margin is a good business, but it is an events business bought by an events business, so the growth argument rests on the same trade-show cycle that already drives the group. The more interesting growth effect is subtractive: removing Taylor & Francis removes the slowest-growing division, which mechanically lifts group growth while removing the thing that cushioned it.

Profitability. Directionally neutral to positive. Clarion's 30%-plus adjusted operating margin is below Taylor & Francis's 36.6%, so a group that acquires one and separates the other does not obviously end up with a higher margin. The £50m of cost synergies is the swing factor, and against it sits around £50m of one-off delivery costs.

Solvency. This is where the scrutiny belongs, and it is the factor the 3% share price move says least about. The cash goes out at completion in the fourth quarter of 2026. The equity raise covers £940m of it; the balance is debt. Management's sub-3 times and sub-2.5 times leverage markers are guidance, not outcomes, and they are set before anyone knows what Taylor & Francis fetches. A separation process that reports in March 2027 is a long time to hold a leverage assumption that depends on it.

Reward/Risk. The shape is asymmetric in time rather than in magnitude. The costs — £2.24bn, £940m of dilution, c.£50m of integration spend, higher leverage — are all 2026 and 2027 events. The benefits — £75m of combined synergies, a re-rated pure-play multiple, Taylor & Francis proceeds — are 2027 to 2029 events. Nothing about that is unusual for M&A, but it does mean the next four quarters are the period in which the thesis can only be damaged, not confirmed.

The read-across

For the UK-listed information and events sector, this is the clearest statement yet that the market prices exhibitions and academic publishing on different multiples, and that boards have noticed. Informa is explicitly choosing to be valued as an events company. That puts a question to every remaining UK conglomerate with a high-margin publishing or data asset sitting inside a faster-growing business, RELX and Pearson included, about whether the sum of their parts is being recognised. It is a different question for each — RELX's analytics and risk businesses are not a drag in the way a slow-growing publisher is — but the Informa precedent makes it harder to leave unanswered.

For the private equity side, Blackstone exiting Clarion to a strategic buyer, after a sale auction was shelved, tells you something about where the bid for events assets currently sits: with trade buyers who can underwrite cost synergies, rather than with financial buyers underwriting leverage. That matters for how the next events asset gets priced.

For the academic publishing sector, the separation process creates a visible, sizeable asset in a market with few buyers. Whether Taylor & Francis ends up demerged, sold to a trade buyer or sold to private capital will be read as a verdict on how the market values subscription-based academic revenue in 2027, and investors screening the sector on our screener will have a fresh reference point when it lands.

What to watch next

• Fourth quarter of 2026 — Clarion completion. The deal is subject to customary regulatory clearances. Clarion's portfolio includes defence and security exhibitions, which is the kind of asset that can attract a longer look. Completion timing is what moves the leverage into the reported numbers.
• March 2027 — full-year results and the Taylor & Francis outcome. This is the single most important date. Informa has committed to reporting the outcome of the separation review here, and it is where a leverage assumption becomes a leverage fact.
• Full-year 2026 results — the leverage print. Watch whether pro-forma net debt to EBITDA actually comes in below 3 times, and how much of the £2.24bn ended up as debt rather than equity.
• Through 2027 — the £50m cost synergy run-rate. Cost synergies either show up in the margin or they do not, and the first evidence should be visible within a year of completion. The £25m of revenue synergy by 2029 will take considerably longer to assess.
• B2B Live Events underlying growth. Guidance is 7%-plus for 2026. If the rescheduled India, Middle East and Africa brands land in the second half as expected, the full-year figure is the cleanest test of whether the business Informa is doubling down on is still compounding at the rate that justified doing so.